Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Epigenetic Features of Pregnancy-Associated Breast Cancer in Hispanic Women
Population and Health Data Manager
Postdoctoral Fellowships in Health Services Research
Regulation of neuronal motility
Nutrition and Behavioral Core for Cotaim
Recently added grants:
Modifying Young Adult Skin Cancer Risk and Protective Behaviors (UV4.me2):A Hybrid Type 2 Dissemination/Effectiveness Trial
Enhancing Speech Processing In A Rat Model Of Autism Using Vagus Nerve Stimulation
Tapeworm stem cells as drivers of regeneration and reproduction
Regulation of Autophagosome Membrane Dynamics by the Atg8 Family of Proteins
Phase Separation: A New Phase in Decoding Enhancer-dependent Critical Transcriptional Programs by Nuclear Receptors
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44CM027361-000
Application #
3609932
Study Section
Project Start
1992-08-01
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Related projects
NIH 1993
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
NIH 1992
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
Comments
Be the first to comment on Martin Murphy's grant